Clozapine-induced stuttering: epileptic brain activity?
Supprian
T
T
Retz
W
W
Deckert
J
J
D000927:Anticonvulsants / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001921:Brain / Q000503:physiopathology*; D003024:Clozapine / Q000009:adverse effects* / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004569:Electroencephalography / Q000706:statistics & numerical data; D004829:Epilepsy, Generalized / Q000188:drug therapy / Q000503:physiopathology*; D005260:Female; D006801:Humans; D008875:Middle Aged; D010672:Phenytoin / Q000627:therapeutic use; D012563:Schizophrenia, Paranoid / Q000188:drug therapy; D013342:Stuttering / Q000139:chemically induced* / Q000188:drug therapy / Q000503:physiopathology; D014635:Valproic Acid / Q000627:therapeutic use
D000927:Anticonvulsants; D014150:Antipsychotic Agents; D014635:Valproic Acid; D010672:Phenytoin; D003024:Clozapine